MHRA Threat to clinics In communication with the MHRA, they also stated: However, we do have concerns about the level of clinical oversight present in IV vitamin therapy and injection services in general and the appropriacy of such services is currently under review. This review, if deciding on stopping treatment of B12 injections by clinics who do comply with the ridiculous rules of the MHRA, would not only negatively impact the companies and individuals who give B12 injections, but also to the people who rely on them to keep functioning both physically and mentally
Key Points to Remember Regulatory Status: 5-Amino-1MQ has not been evaluated by the FDA for safety or effectiveness and cannot be marketed as a dietary supplement or medicine
Mechanism of Action: Both peptides promote collagen synthesis and tissue repair, but they may do so through slightly different mechanisms
Silences the food noise, curbs the appetite, and feel full longer
When symptoms are present, they are almost always caused by the underlying condition driving the elevation , not by the B12 itself